TBA-354
- Generic Name
- TBA-354
A Multiple Ascending Dose Study With a Dose Formulation Comparison Cohort to Evaluate the Safety, Tolerability, and Pharmacokinetics of TBA-354 in Healthy Adult Subjects
- First Posted Date
- 2015-11-17
- Last Posted Date
- 2019-09-18
- Lead Sponsor
- Global Alliance for TB Drug Development
- Target Recruit Count
- 18
- Registration Number
- NCT02606214
A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TBA-354 in Healthy Adult Subjects
- First Posted Date
- 2014-11-11
- Last Posted Date
- 2019-09-06
- Lead Sponsor
- Global Alliance for TB Drug Development
- Target Recruit Count
- 48
- Registration Number
- NCT02288481
- Locations
- 🇺🇸
Celerion, Lincoln, Nebraska, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath